Dieckmann K P, Loy V
Department of Urology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany.
J Clin Oncol. 1996 Dec;14(12):3126-32. doi: 10.1200/JCO.1996.14.12.3126.
Testicular intraepithelial neoplasia ([TIN], so-called carcinoma in situ of the testis) is hypothesized to be the precursor of testicular germ cell neoplasms. According to previous studies, it can be detected by testicular biopsy. Since patients with a unilateral testicular tumor are at high risk of a second testicular tumor, it seemed feasible to examine the prevalence of contralateral TIN in patients with testicular germ cell cancer and correlate it with the known prevalence of bilateral testicular tumors. The aim was to provide more evidence for the role of TIN as the preinvasive stage of testicular cancer.
Nineteen hundred fifty-four consecutive patients with a unilateral testicular germ cell tumor underwent contralateral biopsy. All specimens were examined immunohistologically.
TIN was observed in 4.9% (95% confidence interval [CI], 3.95% to 5.91%). Testicular atrophy and a history of undescended testis were more frequently observed in patients with contralateral TIN, but only atrophy was shown to be independently associated by multivariate analysis. Patients with testicular atrophy have a 4.3-fold increased risk of having contralateral TIN. Sixty-four percent of TIN cases were found in normal testes. Patients with TIN were significantly younger than those without (P < .0017). Three patients developed a second testicular tumor despite a negative biopsy for TIN.
The prevalence of contralateral TIN corresponds well to the known prevalence of bilateral testicular tumors. Testicular atrophy is a strong indicator for the presence of TIN, but approximately 60% of TIN cases occur without atrophy. The present data are in accordance with the theory that TIN is an early step in the histogenesis of testicular germ cell neoplasms.
睾丸上皮内瘤变([TIN],即所谓的睾丸原位癌)被认为是睾丸生殖细胞肿瘤的前驱病变。根据以往研究,可通过睾丸活检检测到。由于单侧睾丸肿瘤患者发生对侧睾丸肿瘤的风险较高,因此检查睾丸生殖细胞癌患者对侧TIN的患病率并将其与已知的双侧睾丸肿瘤患病率相关联似乎是可行的。目的是为TIN作为睾丸癌浸润前期的作用提供更多证据。
1954例连续的单侧睾丸生殖细胞肿瘤患者接受了对侧活检。所有标本均进行免疫组织学检查。
观察到TIN的患病率为4.9%(95%置信区间[CI],3.95%至5.91%)。对侧存在TIN的患者更常出现睾丸萎缩和隐睾病史,但多因素分析显示只有萎缩与TIN独立相关。有睾丸萎缩的患者发生对侧TIN的风险增加4.3倍。64%的TIN病例发现于正常睾丸。有TIN的患者明显比没有TIN的患者年轻(P <.0017)。3例患者尽管TIN活检为阴性,但仍发生了对侧睾丸肿瘤。
对侧TIN的患病率与已知的双侧睾丸肿瘤患病率相符。睾丸萎缩是存在TIN的有力指标,但约60%的TIN病例在无萎缩的情况下发生。目前的数据符合TIN是睾丸生殖细胞肿瘤组织发生早期阶段的理论。